United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 21, 2026 · Filed Sep 22, 2026

On Sep 21, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$494.55 for US$4.7M under a trading plan, leaving 324,443 shares. Filed Sep 22, 2026 (Form 4).

Sold
9,500 shares
Price
US$494.55 average (US$492.97 to US$496.62)
Value
US$4.7M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 21, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 21, 2026Common StockSale1,520US$492.97332,423Indirect
Sep 21, 2026Common StockSale2,680US$493.60329,743Indirect
Sep 21, 2026Common StockSale2,170US$494.82327,573Indirect
Sep 21, 2026Common StockSale2,287US$495.71325,286Indirect
Sep 21, 2026Common StockSale843US$496.62324,443Indirect

Source

View original at SEC

Related